Latest News and Press Releases
Want to stay updated on the latest news?
-
ALBANY, N.Y., Jan. 03, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
-
ALBANY, N.Y., Dec. 20, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
-
ALBANY, N.Y., Nov. 28, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
-
ALBANY, N.Y., Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access,...
-
ALBANY, N.Y., Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access,...
-
New Senior Credit Facility Includes a $100 Million TLA and a $150 Million RCFBoard of Directors Authorizes Up to $25 Million in Share RepurchasesALBANY, N.Y., Nov. 09, 2016 (GLOBE NEWSWIRE) --...
-
ALBANY, N.Y., Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
-
ALBANY, N.Y., Nov. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
-
Q1 net sales of $88.1 million, up 5% year-over-yearQ1 GAAP earnings per share of $0.04; non-GAAP adjusted EPS of $0.17Q1 operating cash generation of $7.4 millionFY2017 guidance remains unchanged ...
-
ALBANY, N.Y., Sept. 21, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...